Omar RF, Gelboin HV, Rahimtula AD (1996) Effect of cytochrome P450 induction on the metabolism and toxicity of ochratoxin A
Research suggests possible anti-inflammatory effects, offering potential benefits in dermatology and systemic inflammatory conditions
New, unusually severe, or increasingly frequent migraines should be discussed with the prescribing clinician
Before starting GLP-1 treatment , inform your GP about: Current or previous anxiety disorders , including generalised anxiety disorder, panic disorder, social anxiety, or health anxiety Other mental health conditions such as depression, eating disorders, or obsessive-compulsive disorder Current psychiatric medications , as weight loss may affect medication requirements though GLP-1 medications themselves have few direct drug interactions Previous experiences with weight loss or diabetes medications and any associated mood changes Your support network and coping strategies for managing stress and anxiety Your GP can help establish baseline mental health status and develop a monitoring plan
